Factbox: Trump's tariffs and threatened trade actions
EU regulator rejects Eli Lilly's Alzheimer's drug (updated)
EU medicines regulator rejects Eli Lilly's Alzheimer's drug
Notice Concerning Commencement Of Tender Offer For EcoNaviSta
Brief: Econavista Inc- Announcement On Expression Of Opinion In Favor Of And Recommendation To Accept A Tender Offer By Eisai Co.
Factbox: Trump's tariffs and threatened trade actions
Factbox: Trump's tariffs and threatened trade actions
EU regulator completes safety review of Eisai-Biogen's Alzheimer's drug without changes (updated)
Brief: EMA's CHMP Says Opinion Recommending Marketing Authorisation For Leqembi Not Need To Be Updated
Factbox: All of Trump's tariffs and threatened trade actions
Factbox: All of Donald Trump's tariffs and threatened trade actions
Brief: BioArctic Says Sales Of Leqembi Reached EUR 200 Million In Eisai FY 2024
Health Rounds: Hormone delivery via skin patch may ease prostate cancer treatment side effects
What to Watch in the Day Ahead - Wednesday, February 12
Factbox: All of Donald Trump's tariffs and threatened trade actions
What to Watch in the Week Ahead and on Monday, February 10
Brief: BioArctic Says Sales Of Leqembi Totaled 13.3 Bln Yen In Q4 2024
Table: Eisai -9-MTH group results (IFRS)
Europe to review safety data for Eisai-Biogen Alzheimer's drug (updated)